ClearPoint Neuro, Inc. (CLPT) stock news
The latest ClearPoint Neuro, Inc. news and press releases. 0 news stories in the last 24 hours. CLPT stock report · Market news
Latest news
- ClearPoint Neuro: Momentum Building Across The Business Seeking Alpha, Nov 9, 5:56 AM UTC
ClearPoint Neuro (CLPT) delivered solid Q3 results, with CAL service revenue ramping and capital equipment sales providing encouraging signs of future disposables growth. Multiple Phase III trials are also expected in... - What ClearPoint Neuro (CLPT) Said on Its Q3 Earnings Call MarketBeat, Oct 29, 2:05 AM UTC
ClearPoint Neuro NASDAQ: CLPT reported third-quarter 2026 revenue growth of 36% as sales increased across its biologics and drug-delivery, neurosurgery navigation and therapy, and capital equipment and software busine... - ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates Zacks Investment Research, Oct 29, 12:31 AM UTC
ClearPoint Neuro, Inc. (CLPT) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.21 per share a year ago. - ClearPoint Neuro, Inc. (CLPT) Q3 2026 Earnings Call Transcript Seeking Alpha, Oct 29, 12:30 AM UTC
ClearPoint Neuro, Inc. (CLPT) Q3 2026 Earnings Call Transcript - CLPT Investors with $100,000 in Losses Have Opportunity to Join ClearPoint Neuro, Inc. Fraud Investigation with SBS Law GuruFocus, Oct 8, 3:00 AM UTC
[url="]Schall, Brown and Schwartz[/url] LLP (âSBSâ), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inv - Cedar Grove Capital Q3 2026 Portfolio Update Seeking Alpha, Oct 7, 7:48 PM UTC
During the quarter, we closed our long positions in MTY Food Group, uniQure, ClearPoint Neuro, and Suja Life Inc. During the quarter, we closed short positions in Bending Spoons SpA, Chipotle Mexican Grill, The Ensign...
Press releases
- ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026 Accesswire, Oct 14, 8:05 PM UTC
SOLANA BEACH, CA / ACCESS Newswire / October 14, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine... - CLPT Investors with $100,000 in Losses Have Opportunity to Join ClearPoint Neuro, Inc. Fraud Investigation with SBS Law Business Wire, Oct 8, 2:12 AM UTC
LOS ANGELES--(BUSINESS WIRE)---- $CLPT--CLPT Investors with $100,000 in Losses Have Opportunity to Join ClearPoint Neuro, Inc. Fraud Investigation with SBS Law.
Headlines link to their publishers. Research data, not investment advice.